VisualDx Unlock Your Unlimited Access to VisualDx Start your 7 day free trial Trusted and used in more than 2,300 hospitals, large clinics, and medical schools to improve clinical decision-making Start Trial Subscriber Sign In
VisualDx VisualDx helps clinicians manage skin concerns at the point of care with trusted visuals, evidence-based guidance, and inclusive images that improve access, reduce unnecessary referrals, and support better patient conversations
Pricing - VisualDx VisualDx provides a far more efficient, systematic, and productive approach to getting the right diagnosis in real-time — the results of which lead to improved patient care, increased provider efficiency and satisfaction, and decreased healthcare costs
Mobile Access | VisualDx Institutional Subscribers Mobile access is included in institutional licenses There are specific mobile download instructions to ensure you can use VisualDx on the go VisualDx Mobile is available as a native iPhone, iPad, and Android apps
VisualDx Login Either the user name or password you entered is incorrect If you have forgotten your password, you can request a new one
Seborrheic dermatitis - VisualDx Seborrheic dermatitis is a common inflammatory papulosquamous condition that affects the sebum-rich areas of the body, including the face, scalp, neck
Rosacea - VisualDx Rosacea is a common, chronic inflammatory condition with a relapsing-remitting course It presents with facial flushing and localized erythema, telang
Clinical decision support platform | VisualDx VisualDx is a clinical decision support platform that helps clinicians think more clearly at the point of care by combining visual comparison with structured clinical context
Vitiligo - VisualDx Vitiligo is an acquired type of leukoderma characterized by well-circumscribed chalk-white depigmented macules or patches Two main clinical categ
What’s New in VisualDx This May See what’s new in VisualDx this May, with deeper hair and scalp image coverage, new diagnoses, and refined clinical content for confident care